GNLX
Price
$2.98
Change
+$0.14 (+4.93%)
Updated
Jul 3 closing price
Capitalization
112.45M
45 days until earnings call
PROK
Price
$0.64
Change
+$0.06 (+10.34%)
Updated
Jul 3 closing price
Capitalization
82.54M
33 days until earnings call
Interact to see
Advertisement

GNLX vs PROK

Header iconGNLX vs PROK Comparison
Open Charts GNLX vs PROKBanner chart's image
Genelux
Price$2.98
Change+$0.14 (+4.93%)
Volume$92.33K
Capitalization112.45M
ProKidney
Price$0.64
Change+$0.06 (+10.34%)
Volume$1.54M
Capitalization82.54M
GNLX vs PROK Comparison Chart in %
Loading...
GNLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GNLX vs. PROK commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNLX is a StrongBuy and PROK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (GNLX: $2.98 vs. PROK: $0.64)
Brand notoriety: GNLX and PROK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNLX: 64% vs. PROK: 145%
Market capitalization -- GNLX: $112.45M vs. PROK: $82.54M
GNLX [@Biotechnology] is valued at $112.45M. PROK’s [@Biotechnology] market capitalization is $82.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNLX’s FA Score shows that 0 FA rating(s) are green whilePROK’s FA Score has 0 green FA rating(s).

  • GNLX’s FA Score: 0 green, 5 red.
  • PROK’s FA Score: 0 green, 5 red.
According to our system of comparison, GNLX is a better buy in the long-term than PROK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNLX’s TA Score shows that 6 TA indicator(s) are bullish while PROK’s TA Score has 3 bullish TA indicator(s).

  • GNLX’s TA Score: 6 bullish, 4 bearish.
  • PROK’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, GNLX is a better buy in the short-term than PROK.

Price Growth

GNLX (@Biotechnology) experienced а -2.30% price change this week, while PROK (@Biotechnology) price change was -11.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

GNLX is expected to report earnings on Aug 19, 2025.

PROK is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GNLX($112M) has a higher market cap than PROK($82.5M). GNLX YTD gains are higher at: 26.271 vs. PROK (-62.296). GNLX has higher annual earnings (EBITDA): -28.78M vs. PROK (-160.12M). PROK has more cash in the bank: 328M vs. GNLX (35.1M). GNLX has less debt than PROK: GNLX (1.79M) vs PROK (3.37M). PROK has higher revenues than GNLX: PROK (306K) vs GNLX (0).
GNLXPROKGNLX / PROK
Capitalization112M82.5M136%
EBITDA-28.78M-160.12M18%
Gain YTD26.271-62.296-42%
P/E RatioN/AN/A-
Revenue0306K-
Total Cash35.1M328M11%
Total Debt1.79M3.37M53%
TECHNICAL ANALYSIS
Technical Analysis
GNLXPROK
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
69%
Momentum
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
65%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
68%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
72%
Advances
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
72%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
52%
Aroon
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
65%
View a ticker or compare two or three
Interact to see
Advertisement
GNLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ICTEF7.920.24
+3.12%
International Container Terminal Services, Inc.
DRYGF0.17N/A
+2.68%
DRYDEN GOLD CORP.
COOSF8.560.22
+2.67%
Carbios SA
AATC7.50N/A
N/A
Autoscope Technologies Corporation
AEDFF73.08N/A
N/A
Aedifica Sicafi, Bruxelles

GNLX and

Correlation & Price change

A.I.dvisor tells us that GNLX and SNSE have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GNLX and SNSE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNLX
1D Price
Change %
GNLX100%
+4.93%
SNSE - GNLX
32%
Poorly correlated
-2.54%
SYRE - GNLX
31%
Poorly correlated
+1.68%
PROK - GNLX
30%
Poorly correlated
+10.11%
CGON - GNLX
30%
Poorly correlated
+2.09%
BHVN - GNLX
29%
Poorly correlated
-0.88%
More

PROK and

Correlation & Price change

A.I.dvisor indicates that over the last year, PROK has been loosely correlated with RXRX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if PROK jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROK
1D Price
Change %
PROK100%
+10.11%
RXRX - PROK
48%
Loosely correlated
+1.15%
IMNM - PROK
42%
Loosely correlated
+2.43%
NAUT - PROK
42%
Loosely correlated
+4.73%
DNLI - PROK
42%
Loosely correlated
-1.41%
ARCT - PROK
42%
Loosely correlated
+1.17%
More